SCHEMBL6069743

SCHEMBL6069743

NCC(=O)Nc1cccc2c1cnn2CCN1CCCC1

nearest known ligand 0.66

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
MCHR1 Q99705 3/20 0.66
SIGMAR1 Q99720 13/20 0.43
MCHR2 Q969V1 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6070033 0.84 MCHR1 (0.77) MCHR1SIGMAR1MCHR2
SCHEMBL6069555 0.80 MCHR1 (0.56) MCHR1SIGMAR1
SCHEMBL6069326 0.80 MCHR1 (0.82) MCHR1MCHR2
SCHEMBL6069418 0.80 MCHR1 (1.00) MCHR1MCHR2
SCHEMBL6069674 0.79 MCHR1 (0.56) MCHR1SIGMAR1
SCHEMBL6070315 0.79 MCHR1 (0.81) MCHR1MCHR2
SCHEMBL6069427 0.79 MCHR1 (0.74) MCHR1MCHR2
SCHEMBL6069546 0.79 MCHR1 (0.69) MCHR1MCHR2
SCHEMBL6069448 0.78 MCHR1 (0.68) MCHR1MCHR2
SCHEMBL6069680 0.77 MCHR1 (0.67) MCHR1MCHR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7071182-B2 Antagonists of melanin concentrating hormone effects on the melanin concentrating hormone receptor ABBOTT LABORATORIES (US) 2006-07-04 US disclosed
US-20050277638-A1 Antagonists of melanin concentrating hormone effects on the melanin concentrating hormone receptor ABBVIE INC. 2005-12-15 US disclosed
US-20050137243-A1 Antagonists of melanin concentrating hormone effects on the melanin concentrating hormone receptor ABBOTT LABORATORIES 2005-06-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050137243-A1 Antagonists of melanin concentrating hormone effects on the melanin concentrating hormone receptor MCHR1, MCHR2, MC1R MCHR1 1/4885SIGMAR1 242/4885MCHR2 2/4885
US-20050277638-A1 Antagonists of melanin concentrating hormone effects on the melanin concentrating hormone receptor MCHR1, MCHR2, MC1R MCHR1 1/4885SIGMAR1 242/4885MCHR2 2/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.